Anthem Biosciences
Consumer
True North, Accel, nine more PE/VCs get exit window as portfolio firms secure IPO nod
Private equity firm True North, venture capital firm Accel and nine other alternative investment firms will get an opportunity to ......
Healthcare
True North plots another benchmark-beating exit move
Homegrown private equity firm True North, which has made several monetisation moves in the last two years while also slashing ......
Healthcare
True North-backed Anthem Bio files for $397 mn IPO
Indian contract drugmaker Anthem Biosciences filed for a 33.95-billion-rupee ($397 million) initial public offering, draft papers showed on Tuesday, at ......
General
Grapevine: General Atlantic, KKR, EQT eye PE deals; FirstCry, Anthem in IPO news
General Atlantic and KKR are among 4-5 private equity firms vying for a majority stake in Faridabad-based hospital chain Asian ......
Healthcare
Bottomline: True North-backed Anthem Bio's margins shrink again, revenue remains in a spot
Anthem Biosciences Pvt Ltd had nearly doubled its revenue in FY21, the same year in which it hit a billion-dollar valuation following ......
Healthcare
Former Biocon execs' CRAMS firm Anthem Bio eyes pre-IPO funding
Bengaluru-based pharma contract research company Anthem Biosciences Pvt. Ltd, which hit the billion-dollar valuation mark two years ago after private ......
Healthcare
True North picks up minority stake in Anthem Biosciences
Homegrown private equity firm True North has signed a definitive agreement with Bengaluru-based Anthem Biosciences Pvt Ltd to acquire a ......
General
Grapevine: True North may buy 10% in Anthem Biosciences; Statkraft eyes Lanco unit
True North may acquire up to 10% stake in Bengaluru-based contract research and manufacturing services firm Anthem Biosciences at a ......
Most Popular
Google News
Follow VCCircle on Google News for the latest updates on Business and Startup News